News Conference News AHA 2025 CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI Michael O'Riordan November 11, 2025
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Daily News EXCEL Data Highlight Bleeding Patterns After CABG, PCI for LM Disease Yael L. Maxwell December 05, 2024
News Conference News NY Valves 2024 Polymer Mitral Valve Shows Well Early, but Long-term Data Key Michael O'Riordan June 12, 2024
News Daily News Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI Michael O'Riordan March 26, 2024
News Daily News TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable Michael O'Riordan January 09, 2024
News Conference News TCT 2022 SCAAR Registry Delves Into Left Main Revascularization Outcomes Michael O'Riordan September 19, 2022
News Conference News ESC 2022 P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER Todd Neale August 29, 2022
News Conference News ACC 2021 Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’ Michael O'Riordan May 18, 2021
News Conference News SCAI 2021 Chinese Registry Supports Prolonged DAPT Following PCI for ACS Yael L. Maxwell May 03, 2021
News Daily News Invasive Approach Best for Cocaine-Linked NSTEMI, but DAPT Is Key Michael O'Riordan March 16, 2021
News Daily News ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes L.A. McKeown July 27, 2020
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for June 2020 Shelley Wood July 02, 2020
News Daily News Balloon-Free PCI for SVG Stenosis Offers Ongoing Advantages: DIVA Caitlin E. Cox February 11, 2020
News Conference News TCT 2019 EXCEL at 5 Years: PCI for Left Main CAD Still Noninferior to CABG Marcus A. Banks September 28, 2019
News Daily News Hybrid Revascularization for Multivessel CAD Rarely Used in the US Todd Neale July 04, 2019